# OrbusNeich tops out R&D and production base in Hangzhou, China

OrbusNeich held a topping-out ceremony for its largest integrated R&D and production base in Fuyang, Hangzhou. The facility, representing a total investment of approximately RMB430 million, is expected to commence full production in 2027, adding 2.4 million units of annual capacity.

- Type: New facility
- Announced: 2025-10-17
- Where: Fuyang, Hangzhou, China
- Value: $60.0M (430.0M CNY)
- Starts operating: 2027
- Status: under construction
- Capacity: 2.4 million units per year
- Products: PCI and PTA intervention products, structural heart disease interventional devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OrbusNeich Medical](https://endata.com/companies/69366.md)

## Sources

- [orbusneich.com](https://orbusneich.com/orbusneich-holds-topping-out-ceremony-for-its-largest-rd-and-production-base-in-hangzhou/), 2025-10-17: "This marked the completion of the structural topping out of OrbusNeich's largest integrated R&D and production facility globally."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.